Valeant Settles with Anacor for $142.5 Million

Oct 29, 2013

Bloomberg Businesweek

The payment will be made by Nov. 8, and it will resolve all disputes between Anacor and Valeant. That includes legal proceedings involving Medicis Pharma, which Valeant acquired in December. Anacor says that Dow Pharmaceutical Services, which is now part of Valeant, breached a contract related to Anacor's work on Jublia. The drug is a treatment for onychomycosis, a fungal infection of the nail and nail bed. Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments